p38 and OGT Sequestration into Viral Inclusion Bodies in Cells Infected with Human Respiratory Syncytial Virus Suppresses MK2 Activities and Stress Granule Assembly

  1. Peter L. Collinsa
  1. aLaboratory of Infectious Diseases
  2. bResearch and Technology Branch
  3. cLaboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
  1. Fig 1

    Western blot analysis of the intracellular expression of p38α, p38-P, and RSV proteins in response to RSV infection and treatment with inhibitor CMPD-1. Monolayer cultures of A549 cells were infected with recombinant wild-type RSV (wt-rRSV) at an MOI of 0.5 or were mock infected. Replicate cultures were treated with the inhibitor CMPD-1 or mock treated, beginning 30 min before infection (−30 min) or 75 min postinfection (+75 min). The cultures were harvested 18 h postinfection and analyzed by Western blotting with antibodies against p38α, p38-P, and purified RSV (which reacted here with the N, P, and SH proteins) and β-actin as a loading control. The antibodies to p38α and p38-P did not cross-react, and different exposure times were used (1 min for p38α, 10 min for p38-P, 20 s for RSV, and 3 s for actin), and thus these results do not indicate the relative abundance of p38α versus p38-P.

  2. Fig 2

    Effect of CMPD-1 treatment on RSV replication and RNA synthesis. Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. Cultures were treated with the inhibitor CMPD-1 or mock treated beginning 75 min postinfection and were incubated for a total of 18 h. (A) RSV replication. The cell culture medium, from two replicate cultures per time point, was collected at 12 h, 18 h, and 24 h postinfection, and viral titers were determined by plaque assay. (B) FISH images of RSV-infected cells. Cultures were fixed and hybridized with a set of RNA probes specific to the N, P, M2-1, NS1, NS2, and F genes (red), and nuclei were stained with DAPI (blue). The samples were analyzed by confocal microscopy.

  3. Fig 3

    Immunofluorescence images of the intracellular distribution of p38-P and the viral M2-1 protein in response to RSV infection and treatment with inhibitor CMPD-1. Monolayers of A549 cell were infected with wt-rRSV at an MOI of 0.5 or were mock infected. The cells were treated with the inhibitor CMPD-1 or mock treated 75 min after infection, incubated for a total of 18 h, fixed, and immunostained using antibodies specific to M2-1 (green) and p38-P (red), and the nuclei were stained with DAPI (blue). The white arrowheads indicate examples of IBs.

  4. Fig 4

    Immunofluorescence imaging and intensity profiles of viral IBs. A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. At 18 h postinfection, the cells were fixed and stained with antibodies for either the viral M2-1 (A, green) or P (B, green) protein and p38-P (red). Nuclei were stained with DAPI (blue). The samples were analyzed by confocal microscopy. In panels A and B, the bottom row of images shows enlargements from the middle row as well as cross-sections in the x and y dimensions. The panels on the right show a single mid-cell layer from a z-stack of confocal images (top images). The white line with arrowheads below each end indicates the track of a line intensity profile across one (A) or two (B) selected IBs (bottom images).

  5. Fig 5

    Western blot analysis of the intracellular expression of MK2 and phosphorylated MK2 (MK2-P) in response to RSV infection and treatment with inhibitor CMPD-1. (A) Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. Replicate cultures were treated with the inhibitor CMPD-1 or mock treated, beginning 30 min before infection (−30 min) or 75 min postinfection (+75 min). Mock-infected cells were treated with arsenite for 30 min at 18 h postinfection as a control. The cultures were harvested and analyzed by Western blotting with antibodies against MK2/MK2-P and β-actin as a loading control. (B) A549 cell cultures were infected or mock infected as for panel A and were treated with arsenite or mock treated for 30 min at 18 h postinfection. The cells were harvested and analyzed by Western blotting with antibodies against MK2/MK2-P, and β-actin was used as a loading control.

  6. Fig 6

    Immunofluorescence analysis of the intracellular distribution of p38-P and viral P (A) or M2-1 (B) protein in response to RSV infection and treatment with arsenite. Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. Cultures were treated with arsenite or mock treated for 30 min at 18 h postinfection, fixed, and immunostained using antibodies to the P (A, green) or M2-1 (B, green) protein and p38-P (red). Nuclei were stained with DAPI (blue). Samples were analyzed by confocal microscopy.

  7. Fig 7

    Immunofluorescence analysis of the intracellular distribution of OGT, the viral P protein, and the SG marker TIA-1 in response to RSV infection and treatment with arsenite. Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. Cultures were treated with arsenite or mock treated for 30 min at 18 h postinfection, fixed, and immunostained using antibodies specific to the P protein (green), OGT (red), and TIA-1 (violet), and nuclei were stained with DAPI (blue). Panel B shows enlargements from the bottom row of panel A, with further enlargements rendered as three-dimensional images. White arrowheads in panel B indicate representative IBs, illustrating that the IBs contain P and OGT but do not localize with TIA-1. An animation of panel B is shown in Video SA in the supplemental material.

  8. Fig 8

    Immunofluorescence analysis of the intracellular distribution of OGT, the viral M2-1 protein, and the SG marker TIA-1 in response to RSV infection and treatment with arsenite. Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. Cultures were treated with arsenite or mock treated for 30 min at 18 h postinfection, fixed, and immunostained using antibodies specific to M2-1 (green), OGT (red), and TIA-1 (violet), and nuclei were stained with DAPI (blue). Panel B shows enlargements from the bottom row of panel A, with further enlargements rendered as three-dimensional images. The white arrowhead in panel B indicates a representative IB containing M2-1 and OGT, but not TIA-1, and the white arrows in panel B indicate representative SGs containing M2-1 and TIA-1. An animation of panel B is shown in Video SB in the supplemental material.

  9. Fig 9

    Immunofluorescence analysis of the intracellular distribution of OGT and OGN in response to RSV infection and treatment with arsenite. Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. Cultures were treated with arsenite or mock treated for 30 min at 18 h postinfection, fixed, and immunostained using antibodies against RSV (green), OGT (red), and OGN (violet). Nuclei were stained with DAPI (blue). Panel B shows enlargements from the bottom row of panel A, with further enlargements rendered as three-dimensional images. Incidentally, the anti-RSV antibodies used in this particular experiment had been raised against whole virus and RSV staining was not limited to IBs; thus, colocalization of viral protein with OGT in IBs (one example is indicated by a white arrowhead in panel B) was much less evident than in other experiments.

  10. Fig 10

    Immunofluorescence analysis of the intracellular distribution of SGs and OGN in response to RSV infection and treatment with arsenite. Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. Cultures were treated with arsenite or mock treated for 30 min at 18 h postinfection, fixed, and immunostained using antibodies against RSV (green), the SG marker eIF3 (red), and OGN (violet). Nuclei were stained with DAPI (blue). Panel B shows enlargements from the bottom row of panel A, with further enlargements rendered as three-dimensional images. White arrows in panel B show examples of colocalization of eIF3 and OGN, indicating that both are in SGs.

  11. Fig 11

    Examples of RSV-infected cells that contain IBs alone or IBs and SGs. Monolayer cultures of A549 cells were infected with wt-rRSV at an MOI of 0.5 or were mock infected. At 18 h postinfection, cells were fixed and immunostained using antibodies specific for M2-1 (green), OGT (red), and TIA-1 (violet). Nuclei were stained with DAPI (blue). White arrowheads indicate an example of a well-developed IB; white arrows indicate areas of SGs. The cell labeled “a” is an example of an RSV-infected cell that contains well-developed IBs and lacks detectable SGs; this pattern was observed in ∼95% of RSV-infected cells. The cell labeled “b” is an example of an RSV-infected cell in which the IBs are smaller and SGs also are present; this pattern was observed in ∼5% of RSV-infected cells.

| Table of Contents
OPEN ACCESS ARTICLE